In talks at the annual meeting of the American Society of Clinical Oncology, experts from Roswell Park will give remarks on racial and ethnic disparities in outcomes among people with metastatic breast cancer; risk patterns for second cancers associated with human papillomavirus (HPV); and effects of immune checkpoint inhibitors (ICI) on cognitive function.

A meta-analysis led by Roswell Park's Muhammad Awidi, MD, has identified key factors that could improve outcomes for cancer patients treated with immune checkpoint inhibitors before or after a solid-organ transplant. The study will be featured as an oral abstract during at the American Society of Clinical Oncology Annual Meeting in Chicago.

New research on children diagnosed with acute lymphoblastic leukemia shows that the longer a patient’s BMI falls within the overweight/obese category during treatment, the greater the risk of relapse and the lower the chance of survival.